<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F3F5883D-A54E-4ACD-9913-10CDADFD78D1"><gtr:id>F3F5883D-A54E-4ACD-9913-10CDADFD78D1</gtr:id><gtr:name>Brighton and Sussex University Hospitals NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3545CDC8-076D-4BD8-B370-8E558F9D46EE"><gtr:id>3545CDC8-076D-4BD8-B370-8E558F9D46EE</gtr:id><gtr:name>Leeds Teaching Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Beckett Street</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS9 7TF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F3F5883D-A54E-4ACD-9913-10CDADFD78D1"><gtr:id>F3F5883D-A54E-4ACD-9913-10CDADFD78D1</gtr:id><gtr:name>Brighton and Sussex University Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3545CDC8-076D-4BD8-B370-8E558F9D46EE"><gtr:id>3545CDC8-076D-4BD8-B370-8E558F9D46EE</gtr:id><gtr:name>Leeds Teaching Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Beckett Street</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS9 7TF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/39F1A6B5-748D-4B32-8738-03E8C9C803FA"><gtr:id>39F1A6B5-748D-4B32-8738-03E8C9C803FA</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Donnelly</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C73A685F-17AF-4901-A775-F18D4592551D"><gtr:id>C73A685F-17AF-4901-A775-F18D4592551D</gtr:id><gtr:firstName>Jenny</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Taylor</gtr:surname><gtr:orcidId>0000-0003-3602-5704</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5610C78F-0D4F-4F40-8E74-C22B7B959A01"><gtr:id>5610C78F-0D4F-4F40-8E74-C22B7B959A01</gtr:id><gtr:firstName>Kate</gtr:firstName><gtr:surname>Dingle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DD01CD01-2036-4695-A53F-20DD2589F57D"><gtr:id>DD01CD01-2036-4695-A53F-20DD2589F57D</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Mant</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/23AB9226-103A-4A9F-BB1B-1E4E1416D034"><gtr:id>23AB9226-103A-4A9F-BB1B-1E4E1416D034</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Peto</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8A411D85-F801-4193-A348-E69C552D94C4"><gtr:id>8A411D85-F801-4193-A348-E69C552D94C4</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Paul</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9B847ED0-D2B1-494D-A537-43DA52723D39"><gtr:id>9B847ED0-D2B1-494D-A537-43DA52723D39</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Klenerman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3CE48284-EB2D-4742-ABF3-FB42AA2FD06F"><gtr:id>3CE48284-EB2D-4742-ABF3-FB42AA2FD06F</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>Nigel</gtr:otherNames><gtr:surname>Monk</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0B94216C-1C6B-4166-B81D-B9C14B3C5151"><gtr:id>0B94216C-1C6B-4166-B81D-B9C14B3C5151</gtr:id><gtr:firstName>E</gtr:firstName><gtr:otherNames>Grace</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/17719B3D-8D27-40E3-967A-65E55AE07A99"><gtr:id>17719B3D-8D27-40E3-967A-65E55AE07A99</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:surname>Hill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A30AC8E4-2B76-42AC-88D0-9EAA115B9349"><gtr:id>A30AC8E4-2B76-42AC-88D0-9EAA115B9349</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Harvey</gtr:otherNames><gtr:surname>Wilcox</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AE0AE02C-7E39-4D6F-8084-52742A2B7152"><gtr:id>AE0AE02C-7E39-4D6F-8084-52742A2B7152</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Wyllie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D5D25B4D-CA52-48D5-9613-BB7DB1AD03A6"><gtr:id>D5D25B4D-CA52-48D5-9613-BB7DB1AD03A6</gtr:id><gtr:firstName>Christine</gtr:firstName><gtr:surname>McCartney</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/43FDE9A5-5329-4CC5-A413-991D1DE52664"><gtr:id>43FDE9A5-5329-4CC5-A413-991D1DE52664</gtr:id><gtr:firstName>Jonathon</gtr:firstName><gtr:surname>Green</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/30297507-9AC8-4973-A857-70E92F3A63AC"><gtr:id>30297507-9AC8-4973-A857-70E92F3A63AC</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4CFEE661-9281-4E12-B253-109123EF97A4"><gtr:id>4CFEE661-9281-4E12-B253-109123EF97A4</gtr:id><gtr:firstName>Ann</gtr:firstName><gtr:otherNames>Sarah</gtr:otherNames><gtr:surname>Walker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/662AA254-25D6-46C5-ADBA-AC9F5512ED22"><gtr:id>662AA254-25D6-46C5-ADBA-AC9F5512ED22</gtr:id><gtr:firstName>Derrick</gtr:firstName><gtr:surname>Crook</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1FD0D626-4BED-4511-8F19-E9D823D31663"><gtr:id>1FD0D626-4BED-4511-8F19-E9D823D31663</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Pollard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/236D4E9F-1D21-4C1B-A859-7A8128054A0C"><gtr:id>236D4E9F-1D21-4C1B-A859-7A8128054A0C</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:surname>Parkhill</gtr:surname><gtr:orcidId>0000-0002-7069-5958</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7B6FDBB3-6434-4F29-8793-7DB47A042603"><gtr:id>7B6FDBB3-6434-4F29-8793-7DB47A042603</gtr:id><gtr:firstName>Rosalind</gtr:firstName><gtr:otherNames>May</gtr:otherNames><gtr:surname>Harding</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0800778"><gtr:id>75C9BAF1-4781-4251-AA2D-5FB8962127CE</gtr:id><gtr:title>MODERNISING MEDICAL MICROBIOLOGY: ESTABLISHING HOW NEW TECHNOLOGIES CAN BE OPTIMALLY INTEGRATED INTO MICROBIOLOGY</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800778</gtr:grantReference><gtr:abstractText>Successful control of infectious diseases depends on completely understanding how they are transmitted. The major challenges posed by tuberculosis, MRSA and hospital acquired diarrhoeas (C. Difficile and norovirus) would be easier to tackle if we could recognise individual outbreaks of infection with different strains. However, current typing schemes, which try to classify how different bugs are related to each other, are too slow and inadequate to reliably do this. 

High-throughput sequencing of the human genome has revolutionised scientific research. We intend to exploit these advances to improve infectious diseases clinical practice. We will systematically collect strains of four pathogens from major UK hospitals and the clinical details of each case. The genomic techniques will allow us to precisely type large numbers of isolates so that we can track individual local outbreaks even if the bugs are very closely related. Better descriptions of routes of transmission will identify where guidelines for infection control can be improved. We will then develop rapid typing techniques so that infection outbreaks can be recognised and followed in real-time, and then successfully interrupted in a rational way. We will develop a web-based computer database so that a single system can be used across the country.</gtr:abstractText><gtr:technicalSummary>Three areas continue to challenge medical microbiology: detecting and managing outbreaks, identifying microbial pathogenic factors causing specific disease manifestations, and understanding the contribution of human host susceptibility. Ongoing advances in sequencing, bioinformatics and web-based technologies have now reached a stage where their potential for revolutionising the way we characterise microbes and investigate human disease can be envisaged. The real challenge is to harness and translate this potential into clinical practice and public health.

The goal of this Consortium is therefore to transfer new and established sequencing technologies into effective everyday public health and clinical microbiology practice.

Specific primary objectives are (i) at a national level, to rapidly detect and track the spread of new epidemic strains (ii) at a local level, to identify hitherto unrecognised outbreaks within an endemic setting, by coupling more discriminatory sequence typing with carefully defined sampling frames (iii) at an individual patient level, to recognise and follow outbreaks early enough to intervene effectively (iv) to develop attractive, easy-to-use web-accessible bioinformatics tools enabling local practitioners to direct routine infection control practices efficiently. Our secondary objective is to enable future population-based studies of microbial pathogenic factors and host genetically-determined susceptibility by assembling isolate collections and matched human DNA. 

Our strategy focuses on four major pathogens providing diverse challenges and varying potential for successful application. We will use ultra-fast whole genomic sequencing to identify regions of informative diversity to augment established and lower resolution typing schemes, and to achieve sufficient power to detect transmission even of highly prevalent pathogenic strains. Rigorous population-based sampling frames appropriate for each organism will be defined, relevant clinical/epidemiological data collected, and infecting organisms and host DNA archived. Improved typing schemes will be implemented using established sequencing platforms, and outputs integrated in a single web-based environment for reporting and analysis. This should deliver near-real-time data-driven national surveillance and local clinical decision making, and could be integrated into the HPA Regional Microbiology Network (RMN). 

To realise our scientific goal we will draw together the breadth of the HPA RMN, research strengths of the University of Oxford, and the sequencing/informatic resources of the Wellcome Trust Sanger Institute, enhancing training opportunities and leadership development in cutting-edge technologies for a large pool of microbiologists. UK capacity will be strengthened by creating a novel partnership with national reach, nurturing research trainees, developing practical software and analytical tools and assembling large well-defined sample archives.</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2588140</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Regional Centre for Mycobacteriology</gtr:department><gtr:description>Birmingham Regional Centre for Mycobacteriology</gtr:description><gtr:id>F1F6FB50-A0BF-405C-99BA-2E6AE6647C29</gtr:id><gtr:impact>Peer-reviewed publications.</gtr:impact><gtr:partnerContribution>Large retrospective sample collection of M. tuberculosis. Substantial intellectual contribution to the project.</gtr:partnerContribution><gtr:piContribution>Sequencing samples, analysis and interpretation of results</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leeds Teaching Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Microbiology Department</gtr:department><gtr:description>Leeds Teaching Hospitals NHS Trust</gtr:description><gtr:id>1E90B108-49CE-4476-A1F7-0CBA5EB56BCB</gtr:id><gtr:impact>Publications in peer-reviewed journals.</gtr:impact><gtr:partnerContribution>Have contributed samples, have conducted a large retrospective study of C. difficile transmission, and a prospective study of Norovirus transmission. Have made a substantial intellectual contribution to the project.</gtr:partnerContribution><gtr:piContribution>Access to sequencing, analysis and interpretation of results</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Public Health England (PHE)</gtr:description><gtr:id>9E5A70EA-E86F-44E8-8936-0D4FEEA0F8F2</gtr:id><gtr:impact>Successful translation of next generation sequencing into public health microbiology</gtr:impact><gtr:partnerContribution>Access to S. aureus, Norovirus, C. difficile and TB samples and related epidemiological data. Staff to collect the samples and data and to ship this to Oxford and the Wellcome Trust Sanger Institute for sequencing. As well as intellectual input into the research. 

Member of REHAB Steering Committee</gtr:partnerContribution><gtr:piContribution>Access to sequencing data and research results.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Infectious Diseases and International Health</gtr:department><gtr:description>University of Virginia</gtr:description><gtr:id>BBE0CCA0-C395-40DF-B4B8-F43D07F0931D</gtr:id><gtr:impact>None as yet.

Partnership is multidisciplinary: including bioinformatics, statistical genetics, microbiology, infectious diseases and epidemiology</gtr:impact><gtr:partnerContribution>Provided the most comprehensive consecutive sequential isolates representing transmission of multidrug resistant organisms in an intensive care unit</gtr:partnerContribution><gtr:piContribution>Undertook sequencing of over 400 carbapenamase-producing Enterebactereaciae and trained a clinical academic on sabbatical in bioinformatic and other analysis technique.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brighton and Sussex University Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Brighton and Sussex University Hospitals NHS Trust</gtr:description><gtr:id>38FAB173-FC19-4A85-86C2-8EC496DABF16</gtr:id><gtr:impact>Publications submitted to peer-reviewed journals on study findings.</gtr:impact><gtr:partnerContribution>Have conducted a large observational study of S. aureus transmission in the Intensive Care Unit. Substantial intellectual contributions to the project.</gtr:partnerContribution><gtr:piContribution>Sequencing samples, analysis and interpretation of results</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Sanger Institute</gtr:description><gtr:id>063E2987-09F8-436D-8EB1-85DBAD68EAD9</gtr:id><gtr:impact>Whole genome sequencing of TB samples and advice. Successful translation of next generation sequencing into public health microbiology.</gtr:impact><gtr:partnerContribution>Access to sequencing machines, staff to process TB samples on these machines and advice</gtr:partnerContribution><gtr:piContribution>Access to TB samples and epidemiological data</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Response to requests from press for opinions</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>169B3236-8802-45F0-ADEE-F20D4A66A98E</gtr:id><gtr:impact>Talked to 4 journalists on different occasions about genomics and infectious disease epidemiology

Coverage in Reuters, The Economist and local newspaper media</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Websites</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>57E071C5-4ED4-4788-9353-B55584239F95</gtr:id><gtr:impact>Contributed and prepared information for websites about the UK CRC Modernising Medical Microbiology Consortium and related research for the public. These websites are; 
o UK CRC Modernising Medical Microbiology Consortium www.modmedmicro.ac.uk
o BRC Infection Theme http://oxfordbrc.nihr.ac.uk/infection/introduction-infection/


n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Infection detectives - mapping outbreaks in the 21st century</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>81D9CA28-0126-4D13-8A44-FE19044E9938</gtr:id><gtr:impact>Public engagement lecture as part of the Oxford BRC series.

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>S. aureus carriage study open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3BD924A0-82B9-40D6-84C6-C01BE9209054</gtr:id><gtr:impact>All participants of the 'S. aureus Carriage Study', were invited to attend this day at the JR hospital

Explaining the research to the participants in the study</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Art shows</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C751D240-55DF-4D3B-A879-41AFB45DAC15</gtr:id><gtr:impact>Anna Dumitriu is currently a Leverhulme Artist in Residence for the UKCRC (MMM) Modernising Medical Microbiology Consortium. Anna has created &amp;quot;The MRSA Quilt&amp;quot; that tells the story of MRSA (Methicillin Resistant Staphylococcus aureus) research and diagnosis through a textile work stained with MRSA bacteria (grown on chromogenic agar) as it undergoes a number of commonly used tests. The final work has been autoclaved and made safe. It has been made in collaboration with Dr John Paul, Dr James Price and has been shown in numerous exhibitions worldwide.

In 2014 Anna's exhibition &amp;quot;The Romantic Disease: An Artistic Investigation of Tuberculosis&amp;quot; has been shown in the UK and the Netherlands.

Relayed the research to the public by art.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newspaper article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EA3FA9F1-25EC-404C-A2EF-F3F796ABB284</gtr:id><gtr:impact>This was titled 'cientists turn DNA detectives to track spread of hospital superbugs Oxford', 4th January 2010

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IORD</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2870D99D-37A4-49C4-903F-95674E93C529</gtr:id><gtr:impact>Presented information about our C. difficile research to the IORD group at the John Radcliffe Hopsital. This group includes patient and public representatives.

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BRC Infection Theme talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>37AC9CD5-0BB6-4CA5-B918-E67D70285D90</gtr:id><gtr:impact>General talks to the public, health care professionals and researchers, on the BRC Infection Theme research, have been undertaken by Prof Derrick Crook in the John Radcliffe Hospital on S. aureus and C. difficile as part of the BRC Open Day (see separate output). About 50-100 people attend the talks.

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BRC open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>47926060-7F81-41A4-B2AF-EB9502694633</gtr:id><gtr:impact>100-500 members of the public attend an annual BRC open day at the John Radcliffe Hospital. Every year we have a stand and activities to engage the public, as well as posters, video and a talk. Interactive exhibitions allow visitors to get hands on with technology and techniques, tackle experiments and even try their hand at investigating genetic relationships using Lego. Researchers from MMM were on hand throughout the day to answer questions on everything from microbiology techniques and infection control in hospitals, to how genetic sequencing is improving treatment. The open day and the research was reported by the BBC Oxford news.

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UKCRC MMM workshops</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>43E9F5F7-D06B-485E-950D-F5D002C554FA</gtr:id><gtr:impact>In 2009/10/11/12/13/14 we have run a UKCRC MMM workshop in Oxford to showcase the work arising from the UKCRC MMM consortium. Between 90-140 attendees attend each year, with diverse backgrounds who engage in discussions about how to translate whole genomic sequencing of pathogens for infection control and public health management. 


Participants report gaining scientific knowledge and further ideas about how to translate genomics into clinical medicine</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford London Lecture series, talk titled 'Gene Revolution'</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CCC79A26-9986-4577-814C-44969E0524D9</gtr:id><gtr:impact>Professor Peter Donnelly referred to the BRC Genomic research in his talk 'The Gene Revolution', Oxford London Lecture series, February 2011.

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Horton Foundation Trust</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C49A7D80-3E70-49A2-830C-18138D30D07C</gtr:id><gtr:impact>Gave a named lecture titled 'Infection control: understanding how we can beat the bugs' to the Horton Foundation Trust staff

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mutamorphosis, Prague</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E7D2287-380C-4A03-AF92-8E6BA8EB27F4</gtr:id><gtr:impact>Just occurring so too early to have results yet

Stimulated a lot of interest from attendees</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Set up patient panels</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A6C923A7-A63A-4C76-A56D-FE14635E5F0F</gtr:id><gtr:impact>We circulated an advert inviting members of the public to join patient panels to inform all aspects of the groups' work. Over 100 individuals responded, and we held two open meetings where different aspects of the work were presented. Following this smaller groups have been set up to review and advise on different projects.

Members of the public have really valued the opportunity to get involved.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>S. aureus research day in London</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>515CA65C-7F35-4AF8-A3EE-22AD6A42ABC0</gtr:id><gtr:impact>A S. aureus research day was held in London, with over a 100 attendees to discuss research options

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1009083</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Environmental REsistome: confluence of Human and Animal Biota in antibiotic resistance spread (REHAB)</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Natural Environment Research Council (NERC)</gtr:fundingOrg><gtr:fundingRef>NE/N019989/1</gtr:fundingRef><gtr:id>5625CE21-E8DD-4446-A5C4-335024CE8B60</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>OXBRC NIHR Fellowship</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Trust</gtr:fundingOrg><gtr:id>4A5592F7-93BB-463D-9B7D-C2F5E91B5358</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>Nuffield Department of Clinical Medicine, University of Oxford, Scientific Leadership Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>NIHR Oxford Biomedical Research Centre</gtr:fundingOrg><gtr:id>D0352ADF-4015-491B-988B-84B092BB42CE</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147340</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>98B54EAE-91AD-498A-8652-1AFF8D33C72F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>355425</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>BCE8AF50-1817-4935-8DA0-61E1B0E066E1</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9138170</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>Oxford Infection Theme, NIHR Biomedical Research Centre Programme</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Trust</gtr:fundingOrg><gtr:id>2A301584-7004-4149-BDEE-7B8A0B2065D8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81995</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR Programme Development Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:fundingRef>RP-DG-1108-10125</gtr:fundingRef><gtr:id>98EDB6FE-6126-49DA-99DF-2E48EC3478FC</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3691617</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>Health Protection Research Unit</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>7E9095E0-30CE-4112-B06D-53318E861ED8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>235032</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Fellowship</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>099423/Z/12/Z</gtr:fundingRef><gtr:id>DC4E3DB2-B88F-4962-ADCE-970BE4426C8E</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165764</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR Flexibility and Sustainability Fund (FSF)</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>E5E44C17-FAE6-477E-8FE4-45D079B5B376</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>C1B097AC-CF8D-47AD-B89C-D928B623B72F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2649834</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR PGfAR (ARK)</gtr:description><gtr:end>2021-02-02</gtr:end><gtr:fundingOrg>National Institutes of Health Research</gtr:fundingOrg><gtr:fundingRef>RP-PG-0514-20015</gtr:fundingRef><gtr:id>3D691060-E053-4917-9AB6-65A8E0C721BA</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2257632</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Gates (CRyPTIC)</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>F557168E-043D-4056-8B29-D39F9B479166</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre and Biomedical Research Unit for Dementia</gtr:department><gtr:description>NIHR Oxford Biomedical Research Centre</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>NIHR BRC Biomedical Research Centre</gtr:fundingOrg><gtr:id>66A43AA9-4A58-456F-9284-A76C141E74CF</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Artist in Residence Scheme, Leverhulme Trust</gtr:description><gtr:fundingOrg>The Leverhulme Trust</gtr:fundingOrg><gtr:id>B064C93A-B45C-4EE2-8FE0-56E2507B322E</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>196069</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Training Fellowship</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J011398/1</gtr:fundingRef><gtr:id>A5E80ADC-B72F-41AB-82C1-1B2865648517</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Institut Biomerieux</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Merieux Institute (Institut M?rieux)</gtr:fundingOrg><gtr:id>E206B4F9-8218-4905-A654-FD99DA0502C0</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2845822</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Innovation Challenge Fund</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>7A127C5C-933B-4463-8E37-C03EB477A7D2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HPA Fellowship (2 people)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Public Health England (formerly: Health Protection Agency)</gtr:fundingOrg><gtr:id>FC9CD1C5-B2CA-43F6-B817-64A217E091C7</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>181530</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Fellowship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>77533C97-7CB0-4018-B85C-36A6F0883410</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Value in People Award</gtr:description><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>44B981F2-8FB8-4452-BADE-F157F6B8599F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3999868</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Collaborative Award (CRyPTIC)</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>2C56EC23-6EA8-48E5-A558-F5966703FFB0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chapter within Part II of CMO's Annual Report on Healthcare Associated Infections</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76CD59E9-F993-4F2B-A42B-D086C261C685</gtr:id><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Blackett Review</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>21976399-81DB-4EAE-AF87-58E568AEBE30</gtr:id><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HPA Bioinformatics Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>14A6C5A1-789B-4FFC-AFB9-8023D9A721F3</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Pathogen whole genome sequencing is under evaluation in S. aureus, C. difficile, Norovirus, M. tuberculosis and E. coli as a tool to enable tracking transmission of pathogens at a local, regional and national level. The main product is single nucleotide variant thresholds to rule in and rule transmission. The main source of funding is the ongoing MMM award.</gtr:description><gtr:id>C9432C9E-EB13-4B60-A4B2-4FDCFC9FC4DC</gtr:id><gtr:impact>The project has demonstrated the feasibility of using whole genome sequencing to track infectious pathogens. It is now being evaluated in large scale studies.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Pathogen whole genome sequencing for transmission and resistotyping</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An existing Multilocus Sequence Typing (MLST) scheme for C. difficile, that was critically limited in its typing resolution by its choice of relatively non-variable and difficult-to sequence target genes, has recently been modified in Oxford. This novel extended scheme currently achieves resolution at least equal to ribotyping and can be further refined using additional loci to achieve greater resolution. A paper describing this scheme has been recently been published by the Journal of Clinical Microbiology (see details below). The revised MLST scheme is now hosted on www.pubmlst.org. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJM, Jolley KA, Kirton R, Peto TE, Ress G, Stoesser N, Vaughan A, Walker SA, Young BC, Wilcox M, Dingle KE. Multilocus Sequence Typing of Clostridium difficile. Journal of Clinical Microbiology; 2010 Mar;48(3):770-8. Epub 2009 Dec 30.</gtr:description><gtr:id>0A0A3AE7-6080-440E-915D-0D9EA0FFD9A9</gtr:id><gtr:impact>We have used this technology to track C. difficile around hospitals in Oxfordshire (Plos Med 2012)</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Improved Multilocus Sequence Typing (MLST) scheme for C. difficile</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://pubmlst.org</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99BDD3A8-D334-49C4-84DD-0E3DBC287C4E"><gtr:id>99BDD3A8-D334-49C4-84DD-0E3DBC287C4E</gtr:id><gtr:title>Whole-genome sequencing in hierarchy with pulsed-field gel electrophoresis: the utility of this approach to establish possible sources of MRSA cross-transmission.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/29d33b2935be7a2d1b5513740e5130f4"><gtr:id>29d33b2935be7a2d1b5513740e5130f4</gtr:id><gtr:otherNames>Moore G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A352B82-3D1D-43DF-88BD-F52195C2BDD0"><gtr:id>3A352B82-3D1D-43DF-88BD-F52195C2BDD0</gtr:id><gtr:title>Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB75F993-08F1-432C-BA56-52787A2E5B00"><gtr:id>EB75F993-08F1-432C-BA56-52787A2E5B00</gtr:id><gtr:title>Insights from genomics into bacterial pathogen populations.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33caa8205214f6d1e07cf41a7889044e"><gtr:id>33caa8205214f6d1e07cf41a7889044e</gtr:id><gtr:otherNames>Wilson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B55F7E64-23EC-4D70-92B8-084CA31292A4"><gtr:id>B55F7E64-23EC-4D70-92B8-084CA31292A4</gtr:id><gtr:title>Reply to Mills and Linkin.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba749585359b6d8b0a4c769e7880a6c3"><gtr:id>ba749585359b6d8b0a4c769e7880a6c3</gtr:id><gtr:otherNames>Price JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6F4F164-D3DD-448F-B411-0AC27A3E64B2"><gtr:id>E6F4F164-D3DD-448F-B411-0AC27A3E64B2</gtr:id><gtr:title>Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a55bddf6b58a982ce4fa44d9b7c98601"><gtr:id>a55bddf6b58a982ce4fa44d9b7c98601</gtr:id><gtr:otherNames>Pankhurst LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E7ADE61-4FD4-42AA-939C-BEFAAF408469"><gtr:id>4E7ADE61-4FD4-42AA-939C-BEFAAF408469</gtr:id><gtr:title>Clostridium difficile surveillance: harnessing new technologies to control transmission.</gtr:title><gtr:parentPublicationTitle>Expert review of anti-infective therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1478-7210</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06A330D2-1AD2-48A6-B251-56ED8D544224"><gtr:id>06A330D2-1AD2-48A6-B251-56ED8D544224</gtr:id><gtr:title>Dynamics of acquisition and loss of carriage of Staphylococcus aureus strains in the community: the effect of clonal complex.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/04deadc25ab4fc216f6e7b1a00c74d1c"><gtr:id>04deadc25ab4fc216f6e7b1a00c74d1c</gtr:id><gtr:otherNames>Miller RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BE64B1A-6476-4CB5-B4CC-618232C3B4A0"><gtr:id>2BE64B1A-6476-4CB5-B4CC-618232C3B4A0</gtr:id><gtr:title>Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1f348d127ad0dfafe68772dadfbf883"><gtr:id>d1f348d127ad0dfafe68772dadfbf883</gtr:id><gtr:otherNames>Walker AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F25B8006-B0AC-44D2-8B8E-67718F15F6C6"><gtr:id>F25B8006-B0AC-44D2-8B8E-67718F15F6C6</gtr:id><gtr:title>Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BCD7F653-2776-43C9-9A2D-D887B5DC0C62"><gtr:id>BCD7F653-2776-43C9-9A2D-D887B5DC0C62</gtr:id><gtr:title>Healthcare-associated outbreak of meticillin-resistant Staphylococcus aureus bacteraemia: role of a cryptic variant of an epidemic clone.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/330a23d3a323cc30bbcedd3851e07800"><gtr:id>330a23d3a323cc30bbcedd3851e07800</gtr:id><gtr:otherNames>Miller RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9FE81007-E63A-4CB0-8167-50DF355E19BC"><gtr:id>9FE81007-E63A-4CB0-8167-50DF355E19BC</gtr:id><gtr:title>Inference of the properties of the recombination process from whole bacterial genomes.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1f910cfd938f25e6e6e45c466f2c7dc1"><gtr:id>1f910cfd938f25e6e6e45c466f2c7dc1</gtr:id><gtr:otherNames>Ansari MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4217E533-345F-4019-89B8-98B6037A37F2"><gtr:id>4217E533-345F-4019-89B8-98B6037A37F2</gtr:id><gtr:title>Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012.</gtr:title><gtr:parentPublicationTitle>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1025-496X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0EF74BDB-6946-484C-B6B7-2FF0C51C8F42"><gtr:id>0EF74BDB-6946-484C-B6B7-2FF0C51C8F42</gtr:id><gtr:title>Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37cbe2871213caf27014ec21f7611ef3"><gtr:id>37cbe2871213caf27014ec21f7611ef3</gtr:id><gtr:otherNames>Laabei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3879F8D1-6FE7-43AD-99DE-DF20F1876094"><gtr:id>3879F8D1-6FE7-43AD-99DE-DF20F1876094</gtr:id><gtr:title>Effects of control interventions on Clostridium difficile infection in England: an observational study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384f794748bc85c2fc08a066092b27a1"><gtr:id>384f794748bc85c2fc08a066092b27a1</gtr:id><gtr:otherNames>Dingle KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F78E3B8-AF03-443D-8E8E-F8CA51B9E9AC"><gtr:id>5F78E3B8-AF03-443D-8E8E-F8CA51B9E9AC</gtr:id><gtr:title>Transforming clinical microbiology with bacterial genome sequencing.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF319B5D-5F8B-40C5-9878-D136C6B96505"><gtr:id>EF319B5D-5F8B-40C5-9878-D136C6B96505</gtr:id><gtr:title>Dynamics of MDR Enterobacter cloacae outbreaks in a neonatal unit in Nepal: insights using wider sampling frames and next-generation sequencing.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C7BFE2A-5E77-48D1-8961-E5B8A13BEE93"><gtr:id>7C7BFE2A-5E77-48D1-8961-E5B8A13BEE93</gtr:id><gtr:title>Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cda315f140fbde098a2e2078c5a904e6"><gtr:id>cda315f140fbde098a2e2078c5a904e6</gtr:id><gtr:otherNames>Golubchik T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B641C991-01B6-42F7-861A-D84BE60611B4"><gtr:id>B641C991-01B6-42F7-861A-D84BE60611B4</gtr:id><gtr:title>Asymptomatic Clostridium difficile colonisation and onward transmission.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8BCC22EB-9EC8-4DE1-BBCA-53C549D0D6EA"><gtr:id>8BCC22EB-9EC8-4DE1-BBCA-53C549D0D6EA</gtr:id><gtr:title>The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d338b343841e9319714389d8b64dc3c0"><gtr:id>d338b343841e9319714389d8b64dc3c0</gtr:id><gtr:otherNames>Elliott B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F67DAF1B-F410-4D5D-B3D4-8E9911498583"><gtr:id>F67DAF1B-F410-4D5D-B3D4-8E9911498583</gtr:id><gtr:title>Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during Cardioplegia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d2a56f32e8a45ef16b8b24f34468e69f"><gtr:id>d2a56f32e8a45ef16b8b24f34468e69f</gtr:id><gtr:otherNames>Whittington HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0976188F-4841-4B1B-8116-081D6D59E2C8"><gtr:id>0976188F-4841-4B1B-8116-081D6D59E2C8</gtr:id><gtr:title>Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96C1B048-EA89-4B95-AD5F-3F9CC44B569C"><gtr:id>96C1B048-EA89-4B95-AD5F-3F9CC44B569C</gtr:id><gtr:title>Clinical Clostridium difficile: clonality and pathogenicity locus diversity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384f794748bc85c2fc08a066092b27a1"><gtr:id>384f794748bc85c2fc08a066092b27a1</gtr:id><gtr:otherNames>Dingle KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B3D6B86-59BA-457D-AE87-8CC550BFA62C"><gtr:id>7B3D6B86-59BA-457D-AE87-8CC550BFA62C</gtr:id><gtr:title>A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD53CFD2-5FC4-44C9-A5AC-CD3C5D49D96C"><gtr:id>BD53CFD2-5FC4-44C9-A5AC-CD3C5D49D96C</gtr:id><gtr:title>Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26539e7eb603c0c89233d872dc777b85"><gtr:id>26539e7eb603c0c89233d872dc777b85</gtr:id><gtr:otherNames>Gordon NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF780226-6AC0-4049-83C7-C41FA876FC75"><gtr:id>EF780226-6AC0-4049-83C7-C41FA876FC75</gtr:id><gtr:title>Mobile elements drive recombination hotspots in the core genome of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6711d112e031d4ba468eec992e8f0601"><gtr:id>6711d112e031d4ba468eec992e8f0601</gtr:id><gtr:otherNames>Everitt RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7249308E-16A5-47C8-8498-95B51230C490"><gtr:id>7249308E-16A5-47C8-8498-95B51230C490</gtr:id><gtr:title>Extensive Within-Host Diversity in Fecally Carried Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolates: Implications for Transmission Analyses.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9441CA1B-DF6D-4666-83DB-9EEEC18EA588"><gtr:id>9441CA1B-DF6D-4666-83DB-9EEEC18EA588</gtr:id><gtr:title>Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in Oxfordshire.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0347ea9d1a0409ca2bf2a8ba6ca34273"><gtr:id>0347ea9d1a0409ca2bf2a8ba6ca34273</gtr:id><gtr:otherNames>Votintseva AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06F0D16A-C009-4368-B3AC-C7E800905CB2"><gtr:id>06F0D16A-C009-4368-B3AC-C7E800905CB2</gtr:id><gtr:title>Coalescent inference for infectious disease: meta-analysis of hepatitis C.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e19ee53e4a43825bec4daf0d215717b"><gtr:id>6e19ee53e4a43825bec4daf0d215717b</gtr:id><gtr:otherNames>Dearlove B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D31884C1-7B08-4A8A-A0FC-F1CA3C77CC42"><gtr:id>D31884C1-7B08-4A8A-A0FC-F1CA3C77CC42</gtr:id><gtr:title>Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CAE0A76-7E5A-4A73-853E-E89268CC2494"><gtr:id>6CAE0A76-7E5A-4A73-853E-E89268CC2494</gtr:id><gtr:title>Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9eeb7fb6d6ede19e834acbf74fb395aa"><gtr:id>9eeb7fb6d6ede19e834acbf74fb395aa</gtr:id><gtr:otherNames>Mawer DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E236F46-9E14-4DB3-BCE9-F75C7C728773"><gtr:id>3E236F46-9E14-4DB3-BCE9-F75C7C728773</gtr:id><gtr:title>Identifying lineage effects when controlling for population structure improves power in bacterial association studies.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c6857c0d9437825ac4cb16bcf17d56a"><gtr:id>0c6857c0d9437825ac4cb16bcf17d56a</gtr:id><gtr:otherNames>Earle SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75D69C49-8948-47D8-B704-DAE404E85BBA"><gtr:id>75D69C49-8948-47D8-B704-DAE404E85BBA</gtr:id><gtr:title>Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47cca3568e2853dceb5f855a8a253092"><gtr:id>47cca3568e2853dceb5f855a8a253092</gtr:id><gtr:otherNames>Zervou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F46A2076-804B-4E3F-85B4-63FA0511F630"><gtr:id>F46A2076-804B-4E3F-85B4-63FA0511F630</gtr:id><gtr:title>Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F15D313-73A1-4440-93EF-D200949DBA79"><gtr:id>5F15D313-73A1-4440-93EF-D200949DBA79</gtr:id><gtr:title>A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samples.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e96acf7472fed03d888c989d2cbdcf0e"><gtr:id>e96acf7472fed03d888c989d2cbdcf0e</gtr:id><gtr:otherNames>Batty EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E7EEAFA-97EC-4DA6-8776-D619C31EA3B5"><gtr:id>5E7EEAFA-97EC-4DA6-8776-D619C31EA3B5</gtr:id><gtr:title>Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8C919D6-3F4A-40D8-9538-AF896817199E"><gtr:id>C8C919D6-3F4A-40D8-9538-AF896817199E</gtr:id><gtr:title>Multilocus sequence typing of Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb999814debfd78c1751e7f9a1e690b3"><gtr:id>fb999814debfd78c1751e7f9a1e690b3</gtr:id><gtr:otherNames>Griffiths D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9BFE2B9E-E698-438D-B051-E0312D27A5A7"><gtr:id>9BFE2B9E-E698-438D-B051-E0312D27A5A7</gtr:id><gtr:title>Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0110a66ba0ae8f1bd3dcd299b4b8e9c"><gtr:id>f0110a66ba0ae8f1bd3dcd299b4b8e9c</gtr:id><gtr:otherNames>Young BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C808F2D5-ECD7-42C0-A852-EEF7F42F06B5"><gtr:id>C808F2D5-ECD7-42C0-A852-EEF7F42F06B5</gtr:id><gtr:title>Diverse sources of C. difficile infection identified on whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/763B4628-FDB7-4447-A08E-7796EAEA461B"><gtr:id>763B4628-FDB7-4447-A08E-7796EAEA461B</gtr:id><gtr:title>Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1f348d127ad0dfafe68772dadfbf883"><gtr:id>d1f348d127ad0dfafe68772dadfbf883</gtr:id><gtr:otherNames>Walker AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FBDBE0AD-4A1A-4334-BB4B-2F304042AFDE"><gtr:id>FBDBE0AD-4A1A-4334-BB4B-2F304042AFDE</gtr:id><gtr:title>ClonalFrameML: efficient inference of recombination in whole bacterial genomes.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3b4561cf01b513731abf1179209f974d"><gtr:id>3b4561cf01b513731abf1179209f974d</gtr:id><gtr:otherNames>Didelot X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2CCF0A7-00BC-4ABF-948B-AED196E208EE"><gtr:id>D2CCF0A7-00BC-4ABF-948B-AED196E208EE</gtr:id><gtr:title>Evolutionary history of the Clostridium difficile pathogenicity locus.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384f794748bc85c2fc08a066092b27a1"><gtr:id>384f794748bc85c2fc08a066092b27a1</gtr:id><gtr:otherNames>Dingle KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5FFAEDE6-131F-4211-8774-D92808FF301C"><gtr:id>5FFAEDE6-131F-4211-8774-D92808FF301C</gtr:id><gtr:title>Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f3c5aeb92de5f9eef2a603f8b6d2dded"><gtr:id>f3c5aeb92de5f9eef2a603f8b6d2dded</gtr:id><gtr:otherNames>Bradley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/860E5A67-07AE-4174-AA5D-E3C3C16D57BA"><gtr:id>860E5A67-07AE-4174-AA5D-E3C3C16D57BA</gtr:id><gtr:title>Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e79fcf2077daa4320474aa60e5e21028"><gtr:id>e79fcf2077daa4320474aa60e5e21028</gtr:id><gtr:otherNames>Mathers AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/597DA343-E933-49EF-8F2E-0EACDDED3721"><gtr:id>597DA343-E933-49EF-8F2E-0EACDDED3721</gtr:id><gtr:title>Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3229F175-D8BB-49C1-B839-0F91BE11CBB0"><gtr:id>3229F175-D8BB-49C1-B839-0F91BE11CBB0</gtr:id><gtr:title>Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa0f8cfb85ddb0ef122647c89a9db7f7"><gtr:id>aa0f8cfb85ddb0ef122647c89a9db7f7</gtr:id><gtr:otherNames>Moore CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D409166-ABEC-4758-8806-25494FDB5BCA"><gtr:id>5D409166-ABEC-4758-8806-25494FDB5BCA</gtr:id><gtr:title>Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba749585359b6d8b0a4c769e7880a6c3"><gtr:id>ba749585359b6d8b0a4c769e7880a6c3</gtr:id><gtr:otherNames>Price JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD37582A-9730-41EF-AEFC-542EF9F0A982"><gtr:id>AD37582A-9730-41EF-AEFC-542EF9F0A982</gtr:id><gtr:title>Rapid host switching in generalist Campylobacter strains erodes the signal for tracing human infections.</gtr:title><gtr:parentPublicationTitle>The ISME journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2322d546ae8d862f8b774b7da2599bb2"><gtr:id>2322d546ae8d862f8b774b7da2599bb2</gtr:id><gtr:otherNames>Dearlove BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1751-7362</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB6E9393-1C73-470B-860B-4F0A7553773A"><gtr:id>AB6E9393-1C73-470B-860B-4F0A7553773A</gtr:id><gtr:title>Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0a8aea65a2ad062c34fe13f676541cc"><gtr:id>c0a8aea65a2ad062c34fe13f676541cc</gtr:id><gtr:otherNames>Eyre DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDD36B9C-5281-413B-9020-BE20596A2A7B"><gtr:id>DDD36B9C-5281-413B-9020-BE20596A2A7B</gtr:id><gtr:title>Whole genome sequencing and de novo assembly identifies Sydney-like variant noroviruses and recombinants during the winter 2012/2013 outbreak in England.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af96af6be5fed6cf3304ecfffc78adbf"><gtr:id>af96af6be5fed6cf3304ecfffc78adbf</gtr:id><gtr:otherNames>Wong TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3CB3EAC-E07F-4540-ABF9-9CD5222B12B1"><gtr:id>D3CB3EAC-E07F-4540-ABF9-9CD5222B12B1</gtr:id><gtr:title>Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F0E5F1D-BDCE-4AC9-8F0C-51D0922F27A0"><gtr:id>6F0E5F1D-BDCE-4AC9-8F0C-51D0922F27A0</gtr:id><gtr:title>Whole genome sequencing in the prevention and control of Staphylococcus aureus infection.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba749585359b6d8b0a4c769e7880a6c3"><gtr:id>ba749585359b6d8b0a4c769e7880a6c3</gtr:id><gtr:otherNames>Price JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/395DD29C-B3A2-4B6C-AFEB-CAE3B7F54E98"><gtr:id>395DD29C-B3A2-4B6C-AFEB-CAE3B7F54E98</gtr:id><gtr:title>Genomic tools for evolution and conservation in the chimpanzee: Pan troglodytes ellioti is a genetically distinct population.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce0d37f6c831118dcb2b42a83ae26a0a"><gtr:id>ce0d37f6c831118dcb2b42a83ae26a0a</gtr:id><gtr:otherNames>Bowden R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/443585CB-9043-4701-A51C-5C1CE8618B9B"><gtr:id>443585CB-9043-4701-A51C-5C1CE8618B9B</gtr:id><gtr:title>Within-host evolution of Staphylococcus aureus during asymptomatic carriage.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cda315f140fbde098a2e2078c5a904e6"><gtr:id>cda315f140fbde098a2e2078c5a904e6</gtr:id><gtr:otherNames>Golubchik T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3A4734E-BBB7-4CE3-8FC5-769C7B6A6B64"><gtr:id>F3A4734E-BBB7-4CE3-8FC5-769C7B6A6B64</gtr:id><gtr:title>Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/476fdc4b4f9c066262d17751e908cce9"><gtr:id>476fdc4b4f9c066262d17751e908cce9</gtr:id><gtr:otherNames>Seale AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E25A076-0A3C-45B6-B846-F9A19DF72BD3"><gtr:id>3E25A076-0A3C-45B6-B846-F9A19DF72BD3</gtr:id><gtr:title>Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) cultures.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0347ea9d1a0409ca2bf2a8ba6ca34273"><gtr:id>0347ea9d1a0409ca2bf2a8ba6ca34273</gtr:id><gtr:otherNames>Votintseva AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97A6AEFC-32CF-4DD2-A0A9-EDC9EF48D1B6"><gtr:id>97A6AEFC-32CF-4DD2-A0A9-EDC9EF48D1B6</gtr:id><gtr:title>Multiple-strain colonization in nasal carriers of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0347ea9d1a0409ca2bf2a8ba6ca34273"><gtr:id>0347ea9d1a0409ca2bf2a8ba6ca34273</gtr:id><gtr:otherNames>Votintseva AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BFB73B6-1F5B-4BAB-AFC7-17DDB8ED9073"><gtr:id>1BFB73B6-1F5B-4BAB-AFC7-17DDB8ED9073</gtr:id><gtr:title>Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3786C8DD-893A-4CFE-B5AD-951B8B1CA535"><gtr:id>3786C8DD-893A-4CFE-B5AD-951B8B1CA535</gtr:id><gtr:title>Colonization with Enterobacteriaceae producing ESBLs in children attending pre-school childcare facilities in the Lao People's Democratic Republic.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73baf845cafdc73ad61e92bec2ca251"><gtr:id>d73baf845cafdc73ad61e92bec2ca251</gtr:id><gtr:otherNames>Stoesser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5BB7E04F-838B-4A34-9598-8CC17C725C7D"><gtr:id>5BB7E04F-838B-4A34-9598-8CC17C725C7D</gtr:id><gtr:title>Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800778</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>B7F5A9CA-62C7-4E68-A2B2-3D6CCA85E16B</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>7.3  Management and decision making</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>